In a research report released Tuesday, Cowen analyst Boris Peaker reiterated a Market Perform rating on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), after the company released …
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today …
In a research report issued Friday, Roth Capital analyst Michael Higgins reiterated a Buy rating on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a …
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a …
In a research report released yesterday, Roth Capital analyst Michael Higgins resumed coverage on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a Buy rating and a …
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and …
Centene Corp (NYSE:CNC) shares increased 4.45% in pre-market trading to $84.
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, …
Golar LNG Limited (USA) (NASDAQ:GLNG) increased more than 17% in pre-market trading to $44.27 after the shipping company was chosen as a partner …
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, …
